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Summary: Pregnant rats were fed diets with an Mg2+ content of 40, 12, 6 and 3 mmol/kg from day 10-19 of
pregnancy. There was a linear correlation of non-protein bound Mg2+ between foetal and maternal serum,
between amniotic fluid and maternal serum, and between foetal serum and amniotic fluid, the ratios being 2.7,
2.0 and 1.3 respectively, indicating active transport of Mg2+ üp to a constant concentration gradient by the
placenta. In hearts, increases of Na"1" and Ca2+, and decreases of Mg24" and K+ were observed only in the group
receiving the lowest Mg2"1" supply.
After i.v. injection of MgQh to pregnant rats, Mg2+ was slowly transported from maternal to foetal serum and
more slowly into the amniotic fluid.
The effect of isoproterenol on cardiac electrolyte content in pregnant rats was less than in non-pregnant rats,
and the effect of isoproterenol in foetal rats was smaller than in maternal rats. These results are explained by
inactivation of isoproterenol in the plaeenta, by the small diaplacental transport of isoproterenol and by a
smaller isoproterenol-stimulation of foetal cardiac adenylate cyclase.
Foetäler und materrialer Magnesium-Stoffwechsel: Beeinflussung durch Magnesium-Mangel und durch Iso-
proterenol
Zusammenfassung: Schwangere Ratten wurden vom Tag 10 bis 19 der Schwangerschaft mit einer Diät gefüt-
tert, die 40, 12, 6 und 3 mmol/kg Mg2* enthielt. Es ergab sich für das nicht an Protein gebundene Mg2"1" eine
lineare Korrelation zwischen foetalem und mütterlichem Serum, zwischen Amnionflüssigkeit und mütterli-
chem Serum sowie zwischen foetalem Serum und Amnionflüssigkeit. Das Verhältnis der Mg2+ Konzentratio-
nen betrug für die einzelnen Korrelationen 2,7; 2,0 und 1,3. Daraus ergibt sich, daß M#2+ bis zu einem kon-
stanten Konzenträtionsgradienten angereichert wird.
«
Nur in der Gruppe mit der geringsten Mg^Zufuhr waren im Herzen der Na+- und Ca2*-Gehalt erhöht und
der Mg?+- und K+-Gehalt erniedrigt.
Nach intravenöser Injektion von MgCl2 wurde Mg2* nur sehr langsam vom mütterlichen zum foetalen Serum
und noch langsamer in die Amnionflüssigkeit transportiert.
Die Wirkung von Isoproterenol auf den Elektrolytgehalt des Herzens war bei schwangeren Ratten wesentlich
geringer als bei nicht schwangeren. Bei den Foeten wirkte Isoproterenol noch schwächer als bei den Müttern.
Dieses Ergebnis läßt sich mit einer Inaktivierung des Isoproterenols in der Placenta, mit der geringen Placen-
tapassage von Katecholaminen und mit der geringeren Stimulierbarkeit der foetalen Adenylatcyclase durch
Isoproterenol erklären.
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Introduction
In early stages of foetal development in rats (l, 2)
and chicken (3), the Mg2"1" concentration is higher in
foetal than in maternal serum and decreases with
time. Shortly before birth, the serum Mg2"1" concen-
tration is still higher in foetal than in maternal rat
serum (1,2, 4). During foetal developmerit, the pro-
tein concentration in foetal serum increases. Howev-
er, shortly before birth the protein concentration is
still lower in foetal than in maternal rat serum (l, 2).
Depending on the protein concentration, approxi-
mately one third of Mg2+ in serum is bouiid to pro-
tein particularly to albumin (5). Thus, the ratio of
non-protein bound Mg2+ in foetal to that in mater-
nal serum is still higher than the ratio of total serum
Mg2+. Obviously, the placenta is able to enrich Mg2+
at its foetal site.
When the maternal Mg2"1" supply is insufficient, the
maternal serum Mg2"1" concentration decreases. Bel-
ow a threshold of \0.6 mmol/1 (6), foetal retardation
and resorption (6, 7, 8), foetal anaemia (8), malfor-
mation (7, 8) and a higher mortality of the new-
borns (7) have been observed, corresponding to the
degree of Mg deficiency. A mild Mg deficieiicy in
combination with foetal hypotrophy has also been
found in some pregnant women particularly during
the second half of pregnancy (9). We therefore pro-
duced varying degrees of Mg deficiency in pregnant
rats from day 10 to 19 and studied the Mg2+ concen-
tration in serum and amniotic fluid, and the electro-
lyte contents of hearts and livers from the foetal and
maternal rats.
A knowledge of the electrolyte metabolism of foetal
hearts in Mg deficiency is especially interesting be-
cause it permits an assessment of the risk of foetal
heart damage during tocolysis with -agonists; -ag-
onists induce a reduction of Mg2+ and an iiicrease in
Ca2+ and Na+ content in the myocardium followed
by necroses of heart muscle cells (10, 11). These
harmful -adrenergic effects can be prevented by a
previous Mg2+ supplementation (10, 11). On the
other hand, the effects of Mg deficiency and iso-
proterenol on cardiac electrolytes have been shown
to be additive (12). Therefore, we also compared the
effect of isoproterenol on the eletrolyte conterits of
foetal and maternal hearts.
Materials and Methods
Female Wistar rats weighing 200 g were maintained uiider a 12
hour light-dark cycle and at a temperature of about 20 9C. Virgin
females were mated from 8-10 a. m. and impregnated females
were identified by the presence of copulatory plugs. This day was
designated s day 0 of gestation. Up to day 10, the rat$ were fed
with Altromin (Mg content: 80 mmol/kg) and tap w ter ad
libitum.
Exper imen ta l design
/. Experiment
From day 10-19 of pregnancy, the rats were fed with a synthetic
Mg deficient diet (Ssniff, Soest, FRG); its composition has already
been described (13). This diet (Ca2+ content: 250 riimol/kg) was
supplemented with MgCl2 to a final Mg24" content of 40 mmol/kg,
12 mmol/kg, 6 mmol/kg, and 3 mmol/kg (nbf supplementation).
The rats in each group (number s indicated in tab. 1) were fed
with this diet and distilled water ad libitum.
On day 19, under nembutal anesthesia (50 mg/kg s.c.), amniotic
fluid was sampled. Blood was taken from the foetal hearts by
means of capillaries and from the mother. The capiliaries were
closed at one end and centrifuged for 5 min at 1300 g. Hearts and
livers were removed, cleaned in cold sucrose (100 g/l), frozen in
liquid nitrogen and ffeeze-dried. Foetal livers and maternal
tissues were pulverized. Foetal serum samples from the same
mothers were pooled for determination of Mg2+, Ca2+ and pro-
tein.
//. Experiment
On day 19, under nembutal anesthesia, the afteria and ven fena-
lis were ligated in those pregnant rats fed a diet cpntaining 40
mmol/kg Mg24" or 6 mmol/kg Mg2+ from day 10-19. There fter,
the rats were intravenously injected with 0.5 ml 150 mm l/1
MgCh. At various times up to 200 min p.i. maternal and foetal
blood and amniotic fluid were taken.
///. Experiment
Normally fed pregnant rats on day 20 of pregnancy were subcur
taneously injected with 3 mg/kg isoproterenol. At 2, 4 arid 6 h
p. i., under nembutal anesthesia, blood, amniotic fluid, livers and
hearts were taken from the maternal and foetal rats and treated s
described above. -
i
IV. Experiment \
Normally fed male Wistar rats weighing 250 g were s. c. injected 4
times every other day jwith 3 mg oestradiol, 3 mg progesterone
and with both in combination. After seven; days they were injected
with 3 mg/kg isoproterenol. Six hours after injection of isoprote-
renol the rats were killed.
Analy t ica l procedures
Protein contents were jrneasured in 10 μΐ of foetal and 5 u! of
maternal serum or 10 μΐ amniotic fluid according to Lowry et al,
(14). For the determination of Mg2+ and Ga2+, 100 μ! and 50 μΐ
respectively of amniotic fluid or serurn were diluted with 1.8 ml
trichloroacetic acid (50jg/l) containing l g/l La34" and measured in
an atomic absorption spectrophotometer (Perkin-Elmer, model
300). Phosphate was determined according to Fiske &. Subbarow
(15). Concentrations of non-protein bound Mg2+ and Ca2+ in se-
rum were calculated according to I.e. (16, 17).
For the determination of tissue electrolytes, 3—4 freeze^dried foe-
tal hearts and 20 mg of the other freeze-dried tissues were ashed
overnight in a Low Temperature Asher (Fa. Tracerlab); The ashes
were dissolved in 3 ml 0.1 mol/l HC1. For the determination of
Ca2+, 100 μΐ were diluted with 200 μΐ Millipore water. 20 μΐ in
quadruplicates were injected into a graphite furnace and mea-
sured according to the Perkin Eimer manual.
For the determination of Mg2*, l ml was diluted with 2 ml l g/l
La3+ in 0.1 mol/l HCland measured by flame atomic 358θφΐίοη.
spectrophotometry. For the determination of Na+ and K+, 0.5 ml
were diluted with 0.5 ml 30 rnmol/1 LiCl and measured in a flame
photometer (Beckman). All Solutions were made with Millipore
water.
 % ?
J. Clin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 12
Vormann, F rster and G nther: Foetal and maternal magnesium metabolism 767
Stat is t ica l t rea tment
Determinations in serum and amniotic fhiid were done in dupli-
cate. For the analysis of foetal hearts 3—4 hearts were pooled.
Other tissue analyses were done with 20 mg aliquois in triplicate.
Ali values are expressed s means ±SEM. Tests of significance
were made using Studenfs t- lest for unpaired data.
Results
Serum
When pregnant rats were fed a diet with reduced
Mg2+ content, the Mg2+ concentration in maternal
and foetal serum was lowered. However, the Mg2"*"
concentration in foetal serum is always higher than
in maternal serum (tab. 1). Under the same experi-
mental conditions, the protein content of maternal
and foetal serum remained nearly constant and was
always higher in the maternal serum (tab. 1). Calcu-
lation of the concentration of non-protein bound
Mg2* for individual maternal and foetal serum, as-
suming the pH and albumin-globulin ratio to be the
same, showed a linear correlation (fig. 1); the con-
centration of non-protein bound Mg24" in fetal serum
was 2.7 times higher than in maternal serum over a
wide r nge of Mg2"1" conceritrations. The Ca2+ con-
centration in serum was not affected by Mg deficien-
cy. The concentration of non-protein bound Ca2+
was somewhat higher in foetal than in maternal se-
rum. The difference was not significant (tab. 1).
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However, other Ca2+ binding substances e,g. phos-
phate must be considered. In normal foetal and mat-
ernal serum we found a phosphate concentration of
4.9 ± 0.4 and 2.4 ±0.1 mmol/1 respectively. Other
authors also found a higher phosphate concentration
in foetal serum (2). Mg deficiency had no effect on
the phosphate concentration in serum.
Using the Mg2+-phosphate binding constant of 33
1/mol (18), it can be calculated that in maternal rat
serum maximally 8% and in foetal serum maximally
16% of non-protein bound Mg2+ are bound to phos-
phate. When binding of Ca2+ to phosphate is taken
into account, the effect of phosphate on Mg2 h binding
is somewhat lower. Taking this binding into account,
the foetal-maternal Mg2+ gradient, which amounts
to 2.7 for non-protein bound Mg2+, would be max-
imally reduced to 2.5 for free Mg2+. Therefore, one
can conclude that in the placenta there is a specific
Mg24" transport System, Ca2+ being unaffected.
To test the Mg2* transporting capacity of the placen-
ta, the maternal serum Mg2"1" concentration was ele-
vated by i. v. injection of MgCl·. Thirty minutes after
injection of 0.5 ml 0.15 mol/1 MgCl2, the total Mg2+
in maternal serum of normally fed rats was incfeased
to 4.3 ± 0.2 mmol/1, and thereafter decreased con-
tinuously; after 200 min, the maternal serum Mg2+
concentration was 2.3 ± 0.2 mmol/1. The simültane-
ously measured foetal serum Mg2+ concentration in-
creased only slowly. During the experimental period
up to 200 min no steady state was reached. When the
non-protein bound Mg2+ concentration was calculat-
ed and plotted (fig. 2) it was apparent that the foetal-
maternal Mg2+ concentration gradient was different
from that under physiological conditions. After in-
jection of MgCl2, the free Mg2"1" concentration is
higher in maternal than in foetal serum. Therefore,
under these experimental conditions, net placental
Mg2+ transport occurred along the concentration
gradient and was low. When the same experiment
was done with Mg-deficient rats the same result was
obtained although at a lower Mg24" concentration. In
both experiments, the increase of foetal serum Mg2+
amounted to 0.08 mmol/1 hour.
In lymphoma cells (19) Mg2+ transport can be inhi-
bited by isoproterenol. Therefore, foetal-maternal
Mg2+ distribution was measured 2, 4 and 6 hoürs af-
ter injection of 3 mg/kg isoproterenol to pregüänt
rats. As can be seen from table 2, the foetal Mg2+
serum concentration was reduced, particularly 2 h
after injection, and increased again later. Maternal
serum Mg2+ behaved inversely to foetal serum Mg2+.
Maternal serum Mg2+ was elevated by isoproterenol,
due to Mg2+ release frofn the maternal heart, and
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probably by foetal Mg2"*" diffusing from foetal serum
to maternal serum along the concentration gradient.
The latter conclusion is supported by the fact that
isoproterenol reduced foetal serum Mg24" but did not
change the foetal cellular Mg2* content (s. below,
tab. 4). Ca2+ and protein concentrations in maternal
and foetal serum were not affected by isoproterenol.
120
t (min)
180
Fig. 2. Non-protein bound Mg2+ in maternal (O) and foetal (x)
serum and in amniotic fluid (D) at different times after
intravenous injection of 0.5 ml 0.15 mmol/l MgCb to
pregnant rats after ligation of renal veins and arteries.
Amnio t i c f l u i d (tab. l, 2)
Since the protein and phosphate contents in amniotic
fluid are very low ([P;] = 0.9 ± 0.1 mmol/l), total
Mg2* and total Ca2* concentrations are only some-
what higher than the concentration of free Mg2* and
free Ca2*. When the Mg2* content in the diet was
reduced, the total Mg2* concentration in the amnio-
tic fluid was also reduced. As in the case of foetal
serum, the Mg2"1" concentration in the amniotic fluid
also exhibited a linear correlation when the Mg2*
concentration in amniotic fluid was plotted versus
non-protein bound Mg24" in maternal serum, the
Mg2* concentration in amniotic fluid being always
twice that of non-protein bound Mg2"1" in maternal
serum (fig. 3). As the phosphate concentration in
amniotic fluid is lower than in maternal serum, the
effect of phosphate on Mg2* binding can be neglect-
ed. When the Mg2* concentration in amniotic fluid
was correlated with the concentration of non-pro-
tein bound Mg2* in foetal serum, a linear correlation
was again obtained; the concentration of non-pro-
tein bound Mg2* in foetal serum is about 30%
higher than total Mg2* in amniotic fluid (fig. 4).
The linear relationships indicate that there is a steady
state of Mg2* distribution between these fluids in the
Mg deficiency experiment. After injection of MgCk,
Mg2* uptake into the amniotic fluid was still slower
than Mg2* uptake into foetal serum (fig. 2). In nor-
mal and Mg deficient rats the increase of Mg in the
amniotic fluid amounted to 0.03 mmol/I x h. After
injection of 3 mg/kg isoproterenol, the Mg2* concen-
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Fig. 3. Correlation of non-protein bound Mg2+ in amniotic fluid
and maternal serum. Symbols äs in fig. 1.
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Fig. 4. Correlation of non-protein bound Mg2* in foetal serum
and amniotic fluid. Symbols äs in fig. 1.
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tration in amniotic fluid was not significantly
changed. The Mg2+ concentration gradient between
foetal serum and amniotic fluid was reduced from
1.35 to 1.1 (from tab. 1), due to the decrease of
Mg2"1" in foetal serum.
Interestingly, because of the low protein and phos-
phate content, the non-protein bound Ca2+ concen-
tration in the amniotic fluid is higher than in foetal
and maternal serum. As yet, we have no explanation
for this observation. In Mg deficiency and after in-
jection of MgCl2 or isoproterenol, the Ca2+ concen-
tration in the amniotic fluid was not changed.
Tissue electrolyte contents (tab. 3, 4)
On a dry weight basis, the electrolyte contents are
higher in foetal than maternal tissues with the excep-
tion of Ca2+ in foetal liver.
As Mg2+ and K"1" have a predominantly intracellular
location, foetal liver and myocardial cells have a
higher content of Mg2"1" and a higher intracellular K+
concentration. In earlier experiments with foetal rat
liver (1) we showed that although there was a higher
total Mg2+ content, the concentration of free Mg2+
was not enhanced in foetal liver, indicating a higher
amount of bound Mg2+. This effect can be explained
by the greater number of ribosomes in foetal than in
maternal tissues and by the Mg2"1" binding properties
of these organelles.
The higher content of the preponderantly extracellu-
larly localized Na+ may be due to the higher extra-
cellular fluid volume in foetal tissues. After feeding
the diets with low Mg2+ contents, Na+ and Ca2+ con-
tents in maternal foetal heart were eleväted, and K+
and Mg24" contents were reduced. TJye effect was on-
ly significantly expressed in the group fed with 3
mmöl/kg Mg2+. In liver the effect of Mg deficiency is
smaller thari in heart (20). Thus, no effect was ob-
served in matemal liver, owing to the short experi-
meiital period, whereäs foetal livers showed similar
(but non-significant) changes to those obsefved in
the heart (tab. 3).
In foetal tissues the Mg deficiency-induced alterä-
tions in electrolyte content were more pronounced
than in maternal tissues. This cän be explained by
the higher growth rate of foetal tissues, because the
Mg deficiency-indueed alteratrons in electrolyte con-
tent depend on growth rate (20).
After injection of 3 mg/kg isoprotefenöl Na+ and
Ca2+ contents in the maternal hearts were increäsed,
whereäs the Mg2+content was decreased 2 hours p. i.
and was nörmalized thereafter. The K"1" content was
not signifieantly changed. Thus the alterations are
qualitatively similar to the alterations of electrolyte
content, äs found in experiments with male rats
(12). Höwever, the effects of 3 mg/kg isopröterenöl
in pregnant rats were much smaller than those ob-
served for the same dose in male rats. In the foetal
hearts the effect of isoproterenol was everi smaller
than in maternal hearts (tab. 4).
Tab. 3. Electrolyte content in maternal and foetal heart and liver after feeding a diet of different Mg2+ content from day 10 to 19 of
pregnancy. Mean ± SEM, n = number of pregnant rats.
Significance a p < 0.001 b p < 0.01 < 0.05
Mg2+
in diet
 n
(mmol/
kg)
(mmol/kg dry weight)
K+
Maternal heart
40
12
6
3
n
40
12
6
3
6
6
6
4
6
6
6
4
38.0 ± 0.3
38.0 ±1.1
37.6 ± 0.9
34.1 ± 1.0b
Maternal liver
31.4 ±0.6
31.8 ±0.5
31.2 ±1.0
31.2 ±2.3
2.6 ±0.1
2.9 ±0.1
2.9 ±0.1
3.2 ± 0.9
3.0 ± 0.2
3.2 ± 0.1
3.2 ±0.1
3.0 ± 0.2
142 ±4
141 ±5
137 ±4
155 ± 3C
69 ±3
68 ±1
71 ±3
75 ±6
347 ±8
328 ±9
327 ±5
296 ± 4a
355 ± 12
354 ±7
351 ±9
359 ± 17»
Mg2* Ca2+
(mmol/kg dry weight)
Foetal heart
41.9 ±0.6
42.2 ± 0.7
40.1 ± 0.9
36.8 ± 1.2*
Foetal liver
38.2 + 1.0
38.7 ± 0.8
37.7 ±1.7
34.1 ± 1.5
4.6 + 0.3
4.6 + 0.4
5.0 + 0.3
6.5 + 0.9
2.4 ± 0.3
2.6 + 0.2
2.4 + 0.1
2.6 + 0.3
Na+
218+10
215 + 8
244 + 9
249 ± 8C
,
147 ±6
152 + 11
168 ±3
171 + 8
K+
468 + 8
459 ±6
455 + 8
.382 + 34c
451+20
472 + 24
465 + 25
431 ±25
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Tab. 4. Electrolyte content of maternal and foetal heart 2» 4 and 6 hours after s. c. injection of 3 mg/kg isoproterenol. Mean ± SEM. n ·
number of pregnant rats.
Significance when indicated: a p < 0.001 b p < 0.01 c p < 0.05.
Time after
isopro-
 n
terenol
(h)
Control
2
4
6
Maternal heart
Mg2* Ca2* Na* K*
(mmol/kg dry weight)
6
6
3
3
38.0 ± 0.3
34.3 ± 0.4a
36.6 ± 1.4
37.0 ± 0.9
2.6 ±0.1
3.4 ± 0.2b
3.2 ± 0.2C
3.7±0.1a
142 ±4
183± 10b
170 ±3a
187 ±7a
374 ±8
342 ±5
367 ±9
370 ±8
Foetal heart
Mg2* c.^ Na+ K*
(mmol/kg dry weight)
41. 9 ±0.6
43.6 ± 1.0
43.6 ±1.0
42.0 ±1.6
4.6 ± 0.3
5.7 ± 0.3C
5.4 ± 0.3
5.5 ± 0.3
218 ± 10
232 ±9
192 ±8
212±16
468 ±8
483 ±7
477 ± 18
482 ± 17
Following the injection of isoproterenol, maternal
and foetal livers showed no alteration of electrolyte
contents (not shown). This result is in agreement
with the finding of others (21), demonstrating that
isoproterenol has a rather cardiospecific effect.
The very low effect of isoproterenol in pregnant rats
was not caused by the changed hormonal Situation in
pregnancy. Injection of isoproterenol into non-preg-
nant female rats, male rats and male rats pretreated
with oesträdiol, progesterone and oestradiol-proges-
terone in combination produced the same alterations
in cärdiac electrolyte content äs described for male
rats (12), particularly the drastic increase in cardiac
Ca2* content from 2.8 iri normal rats to 9 mmol/kg
dry weight.
Therefore, one can conclude, that in pregnant rats
the placenta was responsible diminishing the effect
of isoproterenol on the maternal myoeärdial electro-
lyte content.
Discussipn
Our results indicate that there is an active trärisport
of Mg2* in the placenta. 1t seems reasonable to cor-
relate the placental Mg?* traiisport with the syncyti-
um covering the foetal capillaries. The syncytium
contains a brush border like intestinal epithelial cells
and may be able to transport Mg24".
This function may be in arialogy to the Mg?* trans-
port by the epithelial layef of the chorioid plexus,
resultittg in an increased Mg2"1" concentration in the
cerebrospinal fluid (22). However, the direction of
Mg2* transport would be opposite in these two
epithelial layers.
Placental Mg2* transport operates with unchanged
efficiency during Mg deficiency, always producing
the same Mg2"1" concentration gradient over a wide
ränge of free Mg2* concentrations (0.1 to 0.6
mmol/1) in serum. Therefore, maternal serum Mg2*
concentrations can be used äs an index of foetal se-
rum Mg2+ concentrations. However, there is dis-
agreement on the concentration ränge. Dancis et al.
(4) found that the Mg2* concentration gradient
broke down in Mg deficiency. It is possible that the
latter result was due to by foetal death.
The capacity of net Mg2+ transport in the placenta is
rather limited. After elevation of maternal serum
Mg2+ concentration by i. v. MgGb injection, foetal
Mg2"1" concentration increased only slowly. In this
experiment the maternal serum Mg2+ concentration,
increased by i.V. MgCU injection, decreased rapidly.
Since renal excretion was eliminated and foetal Mg2*
uptake was rather slow, the injected Mg2* must have
been taken up by maternal tissues, particularly by
maternal bone. Bone contains about 50% of total
body Mg2*, and Mg2* in bone is in equilibrium with
extracellular Mg2* (5). In agreement with this con-
clusion, injected 28Mg2* was rapidly removed from
rnaternaKsenim with a similar time course and was
rapidly taken up particularly by maternal bone (23)
(essentially by isotopic 28Mg2*- 24Mg2*-exchange).
In agreement with the slow net placental Mg2* trans-
port, 28Mg2* transport (exchange) to foetal serum
was also limited. Immediately after i. v. injection,
?8Mg2* activity in foetal serum reached an almost
constant but low level (23). From this result one can
conclude that the single 28Mg2* ion is transported ra-
pidly across the placenta. However, the number of
transported 28Mg2* ions was rather limited and
28Mg2* that had crossed the placenta was rapidly ex-
changed with foetal tissue Mg2*.
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To define active placental Mg2* transport, the elee-
trical potential difference must be considered. The
transplacental electrical potential difference
amounted to 50 mV in sheep and to 70 mV in goats
(foetus negative) (24). However, there was no con-
centration gradient between foetal and maternäl se-
rum for Na+ and K+ (4,24,25). There is no explana-
tion for this effect. Considering the transplacental
potential difference of 50—70 mV (foetus negative)
and the Mg2* concentration gradient, there should
be an active Mg2+ transport from foetal to maternal
serum if placental Mg2+ transport depends on the
potential difference. However, it is possible that pla-
cental Mg2+ transport is independent of membrane
potential.
Thus placental Mg2+ transport exhibits similar prop-
erties to cellular Mg2+ transport. Intracellular free
Mg24" concentration is also 2—3 times higher than
extracellular free Mg2+ (20) and is probably inde-
pendent of membrane potential.
Mg2+ transport by lymphoma cells (19) involves the
ß-receptor-adenylate cyclase complex. A similar ef-
fect may be involved in placental Mg2+ transport.
After isoproterenol injection there was a transient
decrease in foetal Mg2+ serum concentration.
This may be caused by a net flux of Mg?+ from foetal
to maternal serum along the Mg2+ concentration
gradient. It is possible that the Inhibition of placental
Mg2* transport is caused by isoproterenol-stimula-
tion of adenylate cyclase similar to that in lymphoma
cells (19).
A striking effect is the drastically reduced action of
isoproterenol in pregnant rats and in their foetuses
after a single injection, in comparison with normal
rats. Since pretreatment with corticoids alters iso-
proterenol-sensitivity (26) the effect of pretreatment
with oestradiol and progesterone w,as tested. How-
ever, pretreatment with these horitiones did not alter
the isoproterenol response. Therefore, the pläeenta
seems to reduce the isoproterenol action, probably
by inactivating isoproterenol. The main biotransfor-
mation of isoproterenol is cönvef sioii to 3-O-methyl-
isoprotereriöl by the action of catechol-O-methyl-
transferase (COMT) (27). As the pläeenta contains
monoamine oxidase (MAO) and catechol-O-me-
thyltransferase (for literature^ see Lc. (28))> this
reaction caii oceur. The physiological significance
may be the protection of the foetus against harmful
effects of catecholamines. This effect is suppöfted by
the vefy low diaplacental passage of catecholamines
(28, 29, 30).
Iri late pregnancy in the myocardium of foetal rats
and räbbits the number and affinity of ß-adrenergic
receptors are fully developed (31, 32, 33). However,
maximal Stimulation of adenylate cyclase by ß-ago-
nists in foetal hearts is lower than that of adult hearts
(32, 34). The small isoproterenol response of the
foetuses can be explained by the sum of these effects
and by the higher foetal serum Mg2+ concentration.
If applicable tö humäiis, these fesults show that the
foetus is more protected than its mother during to-
colysis with ß-agonists.
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